A slowly resolving or non-resolving pneumonia (NRP) is a common clinical dilemma, affecting 10-20% of patients hospitalised with community-acquired…

Dr Jeffrey Weitz chaired the symposium and welcomed Dr Christian Ruff, who discussed and summarised recent results from key trials of new oral…

Prof Gregory Lip opened the symposium with a discussion on determining stroke and bleeding risk in atrial fibrillation (AF) patients and their management.

Homozygous familial hypercholesterolaemia (HoFH), a rare inherited lipid disorder usually caused by bi-allelic defects in the LDLR gene, is characterised…

Valvular heart disease is a growing field, and the number of new approaches for percutaneous treatment is increasing rapidly. These procedures usually…

Although the classical risk factors for cardiovascular disease (CVD) are very important, identification of potential novel risk factors could help…

Double orifice mitral valve (DOMV) is a rare congenital mitral valve (MV) disorder. It is associated with other types of congenital heart disease in 45%…

Aortic stenosis (AS), i.e. calcification and obstruction of the aortic valve (AV), is the most common type of valvular heart disease. The therapeutic…

Paraoxonase 1 (PON1) protects against the development of atherosclerosis by hydrolysing damaging lipid peroxides formed in low-density lipoprotein (LDL)…